Back

Developmental determinants of male bias in medulloblastoma

Bianchini, L.; Xu, R.; Filipovic, D.; Benites Goncalves da Silva, P.; Sieber, L.; Akcay, V.; Arnskoetter, F.; Joshi, P.; Nolle, J.; Soliman, T.; Tao, R.; Scheuing, A.; Okonechnikov, K.; Atamian, A.; Zuckermann, M.; Robinson, G. W.; Quadrato, G.; Northcott, P. A.; Kutscher, L. M.

2026-03-25 developmental biology
10.64898/2026.03.25.714163 bioRxiv
Show abstract

Boys experience an overall increased incidence of several childhood cancers, including medulloblastoma, a clinically heterogeneous cerebellar tumor. In subtypes of Group 3 and Group 4 medulloblastoma, males are three times more prevalent than females. As medulloblastoma is suspected to initiate during fetal development, we hypothesized that this sex bias reflects a combination of prenatal, sex-specific developmental processes and somatic alterations. To test these hypotheses, we compiled a large multi-omics dataset from children with medulloblastoma, which revealed sex-specific alterations, including frequent loss of the inactive X chromosome in females with Group 4. Generation of a sex-matched single-cell transcriptome atlas of the developing murine cerebellum enabled investigation of putative developmental factors underlying sex bias. Progenitors giving rise to Group 3/4 subgroups were more abundant, more proliferative, and harbored more open chromatin for recruitment of LMX1A and OTX2, master transcription factors defining Group 3/4 identity. Advanced genetically engineered mouse models and human cerebellar organoids were leveraged to determine whether sexual dimorphism arises from intrinsic or extrinsic factors. These models showed that the XY genotype contributed to the phenotype, but the predominant effect was driven by presence of the male gonadal hormone testosterone. Our findings provide a sex-specific genetic and neurodevelopmental explanation for male bias in an aggressive pediatric brain tumor. Outcomes from this study may inform novel treatment strategies delivered according to sex and are likely to be broadly applicable to other sex-biased malignancies arising in early life. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=79 SRC="FIGDIR/small/714163v1_ufig1.gif" ALT="Figure 1"> View larger version (18K): org.highwire.dtl.DTLVardef@3a06faorg.highwire.dtl.DTLVardef@1a01bb7org.highwire.dtl.DTLVardef@7bc9c2org.highwire.dtl.DTLVardef@fb206d_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Cell Reports
1338 papers in training set
Top 1%
12.7%
2
Nature Communications
4913 papers in training set
Top 13%
12.5%
3
eLife
5422 papers in training set
Top 9%
8.2%
4
Cell
370 papers in training set
Top 3%
6.4%
5
Neuro-Oncology
30 papers in training set
Top 0.2%
6.3%
6
Genes & Development
90 papers in training set
Top 0.1%
4.8%
50% of probability mass above
7
Neoplasia
22 papers in training set
Top 0.1%
4.0%
8
Blood Advances
54 papers in training set
Top 0.4%
3.6%
9
Science Advances
1098 papers in training set
Top 6%
3.6%
10
JCI Insight
241 papers in training set
Top 2%
2.7%
11
PLOS Biology
408 papers in training set
Top 5%
2.6%
12
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 25%
2.6%
13
Developmental Biology
134 papers in training set
Top 1%
2.4%
14
Nature
575 papers in training set
Top 12%
1.5%
15
Neuro-Oncology Advances
24 papers in training set
Top 0.3%
1.5%
16
iScience
1063 papers in training set
Top 22%
1.2%
17
Scientific Reports
3102 papers in training set
Top 68%
1.1%
18
Cell Genomics
162 papers in training set
Top 5%
0.9%
19
Cell Reports Medicine
140 papers in training set
Top 6%
0.9%
20
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.7%
21
Cells
232 papers in training set
Top 7%
0.7%
22
The American Journal of Human Genetics
206 papers in training set
Top 4%
0.7%
23
Developmental Cell
168 papers in training set
Top 12%
0.7%
24
Nature Genetics
240 papers in training set
Top 8%
0.7%
25
EMBO reports
136 papers in training set
Top 7%
0.7%
26
Genome Medicine
154 papers in training set
Top 9%
0.6%
27
Nature Neuroscience
216 papers in training set
Top 7%
0.6%